Uniting expertise to accelerate innovation, delivering transformative impact for patients and their families.


Ipsen has been around for almost one hundred years, and we intend to be around for another hundred. To accomplish this, we are building a high value, sustainable pipeline from research to commercial.

Partnering with Ipsen

As a mid-size pharma, we leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease and Neuroscience. External innovation is at the heart of our strategy. We believe in the expertise of our partners and value the opportunity to collaborate, bringing our skills, experience and global reach to accelerate innovation to bring new medicines to patients.

Driving to win together

Meet Faiçal, Head of Oncology Partnering, and hear how every program is a priority in Ipsen’s pipeline.

Dedicated to our partners

Meet Masha, Director, Partnering, and hear how Ipsen builds a dedicated team for each program to deliver the best medicine to patients.

One team mindset

Meet David, Senior Vice President, Head of External Innovation and Research, and hear how Ipsen’s one team mindset maximizes value and potential for patients.

Author Image

At Ipsen, we believe great partnerships create great possibilities. Data is just the beginning; we go beyond this to translate the clinical benefit into true patient impact. We focus on how one patient will have an enhanced experience because of each innovation and unite expertise to deliver this.

Philippe Lopes-Fernandes

EVP and Chief Business Officer


We are on a mission to deliver at least one new molecular entity or meaningful indication each year, so collaborations with other like-minded innovators are key for our continued growth. Our partners possess a shared energy to create meaningful differences with a sense of urgency and passion to drive programs forward. We collaborate with partners to define a shared vision to unlock the full potential of their assets, achieving mutual success for our partners and Ipsen.

Partnering events

Throughout the year, Ipsen holds numerous events for and with partners. Look through our upcoming events if you are interested in our work and in partnering with us and would like to meet our team.

Top stories in partnering

10 November 2023 2 mins read

Ipsen’s mission to accelerate innovation in oncology

The outputs from the European Society of Medical Oncology (ESMO) Congress this year encompassed several important new data announcements, highlighting key advances in the development…

02 June 2023 1 mins read

Ipsen’s partnership with Marengo

Find out more about how we approach partnerships at Ipsen, where every program is a priority within our pipeline. We sat down with Zhen Su,…

23 May 2023 2 mins read

Applications now open for the 2023 Golden Ticket Competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition is now open! Through our…

12 August 2022 1 mins read

Epizyme welcome to Ipsen

Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.

14 October 2022 2 mins read

Ipsen becomes a founding sponsor of the second Biolabs innovation hub in Europe at Hopital Hotel Dieu, AP-HP

Ipsen announces that it becomes a founding sponsor of the second Biolabs innovation brain hub in Europe at Hopital Hotel Dieu, AP-HP, in Paris, France….



Ipsen is committed to doing business responsibly. Generation Ipsen – For Positive Change unites all our employees behind a fully integrated approach built around four pillars: environment, patients, people and governance.